Robert J. Carpenter, Director at GENZYME CORP (GENZ), sold 20,000 shares at $60.70 ($1.2M) on 2009-05-12, disclosed to the SEC on 2009-05-13.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.28 | 10,000 | $613K | 50.2% |
| 2 | $60.70 | 2,548 | $155K | 12.7% |
| 3 | $60.70 | 7,452 | $452K | 37.1% |
| Total | $60.99 avg | 20,000 | $1.2M | 100% |
| Filing → |
| GENZ | SELL | 2009-05-18 | $690K | — | Filing → |
| GENZ | SELL | 2009-05-14 | $606K | — | Filing → |
| GENZ | SELL | 2007-11-16 | $1.4M | — | Filing → |